Precision Medicine Market Forecast to 2027 - Covid-19 Impact and Global Analysis - - by Technology (Drug Discovery, Companion Diagnostics, Sequencing, Bio-Informatics and Big Data Analytics), Application (Oncology, Respiratory, CNS, Infectious Disease, Immunology, Cardiology and Others), and Geography
Report Code: TIPBT00002184 No. of Pages: 150 Category: Biotechnology Status: Upcoming
Precision medicine is used to characterizing the diseases and detailed study on patient specific information to diagnose. The concept based on rapidly growing in the medical community through expansions in advanced technologies including molecular biomarker analysis, next generation sequencing, bioinformatics and big data analytics. Precision medicine helps to make possible the diagnosis and treatment of various diseases by relying on genomics and specific biomarker techniques. The approach allows researchers and doctors to predict more accurately the treatment and prevention strategies for a particular disease.
The precision medicine market is anticipated to grow with a significant rate in the coming years, owing to factors such as, growing prevalence of cancer, rising adoption of gene therapy to reduce cost burden for such diseases will favors industry expansion. On other hand, the availability of large-scale human genome databases coupled with computational tools are anticipated to provide more growth opportunities for precision medicine market in the forecast period.
The "Global Precision Medicine Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global precision medicine market with detailed market segmentation by technology, application, and geography. The global precision medicine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global precision medicine market is segmented on the basis of technology, and application. The precision medicine market is segmented into drug discovery, companion diagnostics, sequencing, bio-informatics and big data analytics. Based on application, the precision medicine market is classified as, oncology, respiratory, CNS, infectious disease, immunology, cardiology and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global precision medicine market based on technology, and application. It also provides market size and forecast till 2027 for overall precision medicine market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is leading the precision medicine market owing to increasing investment in the field of precision medicine in US, increasing adoption to leading edge technologies coupled with a favorable legal environment created through grants and initiatives by the government are the factors that help to drive the market in the region. However, the Asia-Pacific region is expected to witness significant growth due to rising adoption of gene sequencing and big data analytics, increasing government initiatives and investment in R&D for novel biomarkers used to treat cancer and rapidly growing healthcare expenditure in emerging economies will augment industry size in the region.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key precision medicine manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are F. Hoffmann-La Roche Ltd, Illumina, Inc., Quest Diagnostics Incorporated., Novartis AG, Bristol-Myers Squibb Company, Eli Lilly and Company, QIAGEN, Teva Pharmaceutical Industries Ltd., Pfizer Inc., and IBM among others.
The precision medicine market is anticipated to grow with a significant rate in the coming years, owing to factors such as, growing prevalence of cancer, rising adoption of gene therapy to reduce cost burden for such diseases will favors industry expansion. On other hand, the availability of large-scale human genome databases coupled with computational tools are anticipated to provide more growth opportunities for precision medicine market in the forecast period.
The "Global Precision Medicine Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global precision medicine market with detailed market segmentation by technology, application, and geography. The global precision medicine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global precision medicine market is segmented on the basis of technology, and application. The precision medicine market is segmented into drug discovery, companion diagnostics, sequencing, bio-informatics and big data analytics. Based on application, the precision medicine market is classified as, oncology, respiratory, CNS, infectious disease, immunology, cardiology and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global precision medicine market based on technology, and application. It also provides market size and forecast till 2027 for overall precision medicine market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is leading the precision medicine market owing to increasing investment in the field of precision medicine in US, increasing adoption to leading edge technologies coupled with a favorable legal environment created through grants and initiatives by the government are the factors that help to drive the market in the region. However, the Asia-Pacific region is expected to witness significant growth due to rising adoption of gene sequencing and big data analytics, increasing government initiatives and investment in R&D for novel biomarkers used to treat cancer and rapidly growing healthcare expenditure in emerging economies will augment industry size in the region.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key precision medicine manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are F. Hoffmann-La Roche Ltd, Illumina, Inc., Quest Diagnostics Incorporated., Novartis AG, Bristol-Myers Squibb Company, Eli Lilly and Company, QIAGEN, Teva Pharmaceutical Industries Ltd., Pfizer Inc., and IBM among others.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. PRECISION MEDICINE MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Precision Medicine Market - By Technology
3.2.2. Precision Medicine Market - By Application
3.2.3. Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. PRECISION MEDICINE MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. PRECISION MEDICINE MARKET - GLOBAL ANALYSIS
5.1. GLOBAL PRECISION MEDICINE MARKET OVERVIEW
5.2. GLOBAL PRECISION MEDICINE MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. CLINICAL TRIALS
5.6. EXPERT OPINIONS
6. PRECISION MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - BY TECHNOLOGY
6.1. OVERVIEW
6.2. TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. DRUG DISCOVERY MARKET
6.3.1. Overview
6.3.2. Drug Discovery Market Revenue Forecasts and Analysis (US$ Mn)
6.4. COMPANION DIAGNOSTICS MARKET
6.4.1. Overview
6.4.2. Companion Diagnostics Market Revenue Forecasts and Analysis (US$ Mn)
6.5. SEQUENCING MARKET
6.5.1. Overview
6.5.2. Sequencing Market Revenue Forecasts and Analysis (US$ Mn)
6.6. BIO-INFORMATICS MARKET
6.6.1. Overview
6.6.2. Bio-Informatics Market Revenue Forecasts and Analysis (US$ Mn)
6.7. BIG DATA ANALYTICS MARKET
6.7.1. Overview
6.7.2. Big Data Analytics Market Revenue Forecasts and Analysis (US$ Mn)
7. PRECISION MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - BY APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. ONCOLOGY MARKET
7.3.1. Overview
7.3.2. Oncology Market Revenue Forecasts and Analysis (US$ Mn)
7.4. RESPIRATORY MARKET
7.4.1. Overview
7.4.2. Respiratory Market Revenue Forecasts and Analysis (US$ Mn)
7.5. CNS MARKET
7.5.1. Overview
7.5.2. CNS Market Revenue Forecasts and Analysis (US$ Mn)
7.6. INFECTIOUS DISEASES MARKET
7.6.1. Overview
7.6.2. Infectious Diseases Market Revenue Forecasts and Analysis (US$ Mn)
7.7. IMMUNOLOGY MARKET
7.7.1. Overview
7.7.2. Immunology Market Revenue Forecasts and Analysis (US$ Mn)
7.8. CARDIOLOGY MARKET
7.8.1. Overview
7.8.2. Cardiology Market Revenue Forecasts and Analysis (US$ Mn)
7.9. OTHER APPLICATIONS MARKET
7.9.1. Overview
7.9.2. Other Applications Market Revenue Forecasts and Analysis (US$ Mn)
8. NORTH AMERICA PRECISION MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
8.1. NORTH AMERICA PRECISION MEDICINE MARKET OVERVIEW
8.2. NORTH AMERICA PRECISION MEDICINE MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. NORTH AMERICA PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
8.4. NORTH AMERICA PRECISION MEDICINE MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
8.5. NORTH AMERICA PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
8.6. US MARKET OVERVIEW
8.6.1. US Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
8.6.2. US Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
8.7. CANADA MARKET OVERVIEW
8.7.1. Canada Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
8.7.2. Canada Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
8.8. MEXICO MARKET OVERVIEW
8.8.1. Mexico Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
8.8.2. Mexico Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9. EUROPE PRECISION MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. EUROPE PRECISION MEDICINE MARKET OVERVIEW
9.2. EUROPE PRECISION MEDICINE MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. EUROPE PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
9.4. EUROPE PRECISION MEDICINE MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
9.5. EUROPE PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.6. UK MARKET OVERVIEW
9.6.1. UK Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.6.2. UK Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.7. GERMANY MARKET OVERVIEW
9.7.1. Germany Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.7.2. Germany Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.8. FRANCE MARKET OVERVIEW
9.8.1. France Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.8.2. France Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10. ASIA PACIFIC PRECISION MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. ASIA PACIFIC PRECISION MEDICINE MARKET OVERVIEW
10.2. ASIA PACIFIC PRECISION MEDICINE MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. ASIA PACIFIC PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
10.4. ASIA PACIFIC PRECISION MEDICINE MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.5. ASIA PACIFIC PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.6. JAPAN MARKET OVERVIEW
10.6.1. Japan Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.6.2. Japan Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7. CHINA MARKET OVERVIEW
10.7.1. China Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.7.2. China Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8. INDIA MARKET OVERVIEW
10.8.1. India Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.8.2. India Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11. MIDDLE EAST AND AFRICA (MEA) PRECISION MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. MIDDLE EAST AND AFRICA (MEA) PRECISION MEDICINE MARKET OVERVIEW
11.2. MIDDLE EAST AND AFRICA (MEA)PRECISION MEDICINE MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. MIDDLE EAST AND AFRICA (MEA)PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
11.4. MIDDLE EAST AND AFRICA (MEA)PRECISION MEDICINE MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.5. MIDDLE EAST AND AFRICA (MEA)PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. SOUTH AFRICA MARKET OVERVIEW
11.6.1. South Africa Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.6.2. South Africa Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7. SAUDI ARABIA MARKET OVERVIEW
11.7.1. Saudi Arabia Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.7.2. Saudi Arabia Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8. UAE MARKET OVERVIEW
11.8.1. UAE Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.8.2. UAE Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12. SOUTH AND CENTRAL AMERICA PRECISION MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. SOUTH AND CENTRAL AMERICA PRECISION MEDICINE MARKET OVERVIEW
12.2. SOUTH AND CENTRAL AMERICA PRECISION MEDICINE MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. SOUTH AND CENTRAL AMERICA PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
12.4. SOUTH AND CENTRAL AMERICA PRECISION MEDICINE MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.5. SOUTH AND CENTRAL AMERICA PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.6. BRAZIL MARKET OVERVIEW
12.6.1. Brazil Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.6.2. Brazil Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13. INDUSTRY LANDSCAPE
13.1. ORGANIC GROWTH STRATEGIES
13.1.1. New Product Launches
13.1.2. Marketing & Promotional Activities
13.2. INORGANIC GROWTH STRATEGIES
13.2.1. Partnerships, Collaborations, and Joint Ventures
13.2.2. Mergers & Acquisitions
14. PRECISION MEDICINE MARKET, KEY COMPANY PROFILES
14.1. F. Hoffmann-La Roche Ltd
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. Product Pipeline
14.1.6. SWOT Analysis
14.1.7. Key Developments
14.2. Illumina, Inc.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. Product Pipeline
14.2.6. SWOT Analysis
14.2.7. Key Developments
14.3. Quest Diagnostics Incorporated.
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. Product Pipeline
14.3.6. SWOT Analysis
14.3.7. Key Developments
14.4. Novartis AG
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. Product Pipeline
14.4.6. SWOT Analysis
14.4.7. Key Developments
14.5. Bristol-Myers Squibb Company
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. Product Pipeline
14.5.6. SWOT Analysis
14.5.7. Key Developments
14.6. Eli Lilly and Company
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. Product Pipeline
14.6.6. SWOT Analysis
14.6.7. Key Developments
14.7. QIAGEN
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. Product Pipeline
14.7.6. SWOT Analysis
14.7.7. Key Developments
14.8. Teva Pharmaceutical Industries Ltd.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. Product Pipeline
14.8.6. SWOT Analysis
14.8.7. Key Developments
14.9. Pfizer Inc.
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. Product Pipeline
14.9.6. SWOT Analysis
14.9.7. Key Developments
14.10. IBM
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. Product Pipeline
14.10.6. SWOT Analysis
14.10.7. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
15.3. RESEARCH METHODOLOGY
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. PRECISION MEDICINE MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Precision Medicine Market - By Technology
3.2.2. Precision Medicine Market - By Application
3.2.3. Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. PRECISION MEDICINE MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. PRECISION MEDICINE MARKET - GLOBAL ANALYSIS
5.1. GLOBAL PRECISION MEDICINE MARKET OVERVIEW
5.2. GLOBAL PRECISION MEDICINE MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. CLINICAL TRIALS
5.6. EXPERT OPINIONS
6. PRECISION MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - BY TECHNOLOGY
6.1. OVERVIEW
6.2. TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. DRUG DISCOVERY MARKET
6.3.1. Overview
6.3.2. Drug Discovery Market Revenue Forecasts and Analysis (US$ Mn)
6.4. COMPANION DIAGNOSTICS MARKET
6.4.1. Overview
6.4.2. Companion Diagnostics Market Revenue Forecasts and Analysis (US$ Mn)
6.5. SEQUENCING MARKET
6.5.1. Overview
6.5.2. Sequencing Market Revenue Forecasts and Analysis (US$ Mn)
6.6. BIO-INFORMATICS MARKET
6.6.1. Overview
6.6.2. Bio-Informatics Market Revenue Forecasts and Analysis (US$ Mn)
6.7. BIG DATA ANALYTICS MARKET
6.7.1. Overview
6.7.2. Big Data Analytics Market Revenue Forecasts and Analysis (US$ Mn)
7. PRECISION MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - BY APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. ONCOLOGY MARKET
7.3.1. Overview
7.3.2. Oncology Market Revenue Forecasts and Analysis (US$ Mn)
7.4. RESPIRATORY MARKET
7.4.1. Overview
7.4.2. Respiratory Market Revenue Forecasts and Analysis (US$ Mn)
7.5. CNS MARKET
7.5.1. Overview
7.5.2. CNS Market Revenue Forecasts and Analysis (US$ Mn)
7.6. INFECTIOUS DISEASES MARKET
7.6.1. Overview
7.6.2. Infectious Diseases Market Revenue Forecasts and Analysis (US$ Mn)
7.7. IMMUNOLOGY MARKET
7.7.1. Overview
7.7.2. Immunology Market Revenue Forecasts and Analysis (US$ Mn)
7.8. CARDIOLOGY MARKET
7.8.1. Overview
7.8.2. Cardiology Market Revenue Forecasts and Analysis (US$ Mn)
7.9. OTHER APPLICATIONS MARKET
7.9.1. Overview
7.9.2. Other Applications Market Revenue Forecasts and Analysis (US$ Mn)
8. NORTH AMERICA PRECISION MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
8.1. NORTH AMERICA PRECISION MEDICINE MARKET OVERVIEW
8.2. NORTH AMERICA PRECISION MEDICINE MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. NORTH AMERICA PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
8.4. NORTH AMERICA PRECISION MEDICINE MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
8.5. NORTH AMERICA PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
8.6. US MARKET OVERVIEW
8.6.1. US Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
8.6.2. US Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
8.7. CANADA MARKET OVERVIEW
8.7.1. Canada Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
8.7.2. Canada Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
8.8. MEXICO MARKET OVERVIEW
8.8.1. Mexico Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
8.8.2. Mexico Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9. EUROPE PRECISION MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. EUROPE PRECISION MEDICINE MARKET OVERVIEW
9.2. EUROPE PRECISION MEDICINE MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. EUROPE PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
9.4. EUROPE PRECISION MEDICINE MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
9.5. EUROPE PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.6. UK MARKET OVERVIEW
9.6.1. UK Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.6.2. UK Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.7. GERMANY MARKET OVERVIEW
9.7.1. Germany Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.7.2. Germany Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.8. FRANCE MARKET OVERVIEW
9.8.1. France Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.8.2. France Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10. ASIA PACIFIC PRECISION MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. ASIA PACIFIC PRECISION MEDICINE MARKET OVERVIEW
10.2. ASIA PACIFIC PRECISION MEDICINE MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. ASIA PACIFIC PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
10.4. ASIA PACIFIC PRECISION MEDICINE MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.5. ASIA PACIFIC PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.6. JAPAN MARKET OVERVIEW
10.6.1. Japan Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.6.2. Japan Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7. CHINA MARKET OVERVIEW
10.7.1. China Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.7.2. China Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8. INDIA MARKET OVERVIEW
10.8.1. India Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.8.2. India Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11. MIDDLE EAST AND AFRICA (MEA) PRECISION MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. MIDDLE EAST AND AFRICA (MEA) PRECISION MEDICINE MARKET OVERVIEW
11.2. MIDDLE EAST AND AFRICA (MEA)PRECISION MEDICINE MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. MIDDLE EAST AND AFRICA (MEA)PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
11.4. MIDDLE EAST AND AFRICA (MEA)PRECISION MEDICINE MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.5. MIDDLE EAST AND AFRICA (MEA)PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. SOUTH AFRICA MARKET OVERVIEW
11.6.1. South Africa Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.6.2. South Africa Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7. SAUDI ARABIA MARKET OVERVIEW
11.7.1. Saudi Arabia Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.7.2. Saudi Arabia Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8. UAE MARKET OVERVIEW
11.8.1. UAE Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.8.2. UAE Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12. SOUTH AND CENTRAL AMERICA PRECISION MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. SOUTH AND CENTRAL AMERICA PRECISION MEDICINE MARKET OVERVIEW
12.2. SOUTH AND CENTRAL AMERICA PRECISION MEDICINE MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. SOUTH AND CENTRAL AMERICA PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
12.4. SOUTH AND CENTRAL AMERICA PRECISION MEDICINE MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.5. SOUTH AND CENTRAL AMERICA PRECISION MEDICINE MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.6. BRAZIL MARKET OVERVIEW
12.6.1. Brazil Precision Medicine Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.6.2. Brazil Precision Medicine Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13. INDUSTRY LANDSCAPE
13.1. ORGANIC GROWTH STRATEGIES
13.1.1. New Product Launches
13.1.2. Marketing & Promotional Activities
13.2. INORGANIC GROWTH STRATEGIES
13.2.1. Partnerships, Collaborations, and Joint Ventures
13.2.2. Mergers & Acquisitions
14. PRECISION MEDICINE MARKET, KEY COMPANY PROFILES
14.1. F. Hoffmann-La Roche Ltd
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. Product Pipeline
14.1.6. SWOT Analysis
14.1.7. Key Developments
14.2. Illumina, Inc.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. Product Pipeline
14.2.6. SWOT Analysis
14.2.7. Key Developments
14.3. Quest Diagnostics Incorporated.
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. Product Pipeline
14.3.6. SWOT Analysis
14.3.7. Key Developments
14.4. Novartis AG
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. Product Pipeline
14.4.6. SWOT Analysis
14.4.7. Key Developments
14.5. Bristol-Myers Squibb Company
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. Product Pipeline
14.5.6. SWOT Analysis
14.5.7. Key Developments
14.6. Eli Lilly and Company
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. Product Pipeline
14.6.6. SWOT Analysis
14.6.7. Key Developments
14.7. QIAGEN
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. Product Pipeline
14.7.6. SWOT Analysis
14.7.7. Key Developments
14.8. Teva Pharmaceutical Industries Ltd.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. Product Pipeline
14.8.6. SWOT Analysis
14.8.7. Key Developments
14.9. Pfizer Inc.
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. Product Pipeline
14.9.6. SWOT Analysis
14.9.7. Key Developments
14.10. IBM
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. Product Pipeline
14.10.6. SWOT Analysis
14.10.7. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
15.3. RESEARCH METHODOLOGY
The List of Companies
1. F. Hoffmann-La Roche Ltd
2. Illumina, Inc.
3. Quest Diagnostics Incorporated.
4. Novartis AG
5. Bristol-Myers Squibb Company
6. Eli Lilly and Company
7. QIAGEN
8. Teva Pharmaceutical Industries Ltd.
9. Pfizer Inc.
10. IBM
1. F. Hoffmann-La Roche Ltd
2. Illumina, Inc.
3. Quest Diagnostics Incorporated.
4. Novartis AG
5. Bristol-Myers Squibb Company
6. Eli Lilly and Company
7. QIAGEN
8. Teva Pharmaceutical Industries Ltd.
9. Pfizer Inc.
10. IBM